Person:
Kämpfe, Alexander David

Profilbild
E-Mail-Adresse
Geburtsdatum
1984
Forschungsvorhaben
Organisationseinheiten
Logo der Organisationseinheit
Organisationseinheit
Berufsbeschreibung
Nachname
Kämpfe
Vorname
Alexander David
Name

Filter

20222
Filter zurücksetzen

Einstellungen

Thema: Toxizität ×

Suchergebnisse

Gerade angezeigt 1 - 2 von 2
  • Vorschaubild nicht verfügbar
    Veröffentlichung
    Effects of Zinc Oxide Nanoparticles on model systems of the intestinal barrier
    (2022) Mittag, Anna; Höra, Christian; Owesny, Patricia; Kämpfe, Alexander David
    Zinc oxide nanoparticles (ZnO NP) are often used in the food sector, among others, because of their advantageous properties. As part of the human food chain, they are inevitably taken up orally. The debate on the toxicity of orally ingested ZnO NP continues due to incomplete data. Therefore, the aim of our study was to examine the effects of two differently sized ZnO NP (<50 nm and <100 nm primary particle size; 123â€Ì614 mikromol/L) on two model systems of the intestinal barrier. Differentiated Caco-2 enterocytes were grown on Transwell inserts in monoculture and also in coculture with the mucus-producing goblet cell line HT29-MTX. Although no comprehensive mucus layer was detectable in the coculture, cellular zinc uptake was clearly lower after a 24-h treatment with ZnO NP than in monocultured cells. ZnO NP showed no influence on the permeability, metabolic activity, cytoskeleton and cell nuclei. The transepithelial electrical resistance was significantly increased in the coculture model after treatment with _307 _mol/L ZnO NP. Only small zinc amounts (0.07â€Ì0.65 mikrog/mL) reached the basolateral area. Our results reveal that the cells of an intact intestinal barrier interact with ZnO NP but do not suffer serious damage. Quelle: Artikel
  • Vorschaubild nicht verfügbar
    Veröffentlichung
    Impact of in vitro digested zinc oxide nanoparticles on intestinal model systems
    (2022) Mittag, Anna; Höra, Christian; Singer, Alina; Kämpfe, Alexander David
    Background: Zinc oxide nanoparticles (ZnO NP) offer beneficial properties for many applications, especially in the food sector. Consequently, as part of the human food chain, they are taken up orally. The toxicological evaluation of orally ingested ZnO NP is still controversial. In addition, their physicochemical properties can change during digestion, which leads to an altered biological behaviour. Therefore, the aim of our study was to investigate the fate of two different sized ZnO NP (< 50 nm and < 100 nm) during in vitro digestion and their effects on model systems of the intestinal barrier. Differentiated Caco-2 cells were used in mono- and coculture with mucus-producing HT29-MTX cells. The cellular uptake, the impact on the monolayer barrier integrity and cytotoxic effects were investigated after 24 h exposure to 123-614 mikroM ZnO NP. Results: In vitro digested ZnO NP went through a morphological and chemical transformation with about 70% free zinc ions after the intestinal phase. The cellular zinc content increased dose-dependently up to threefold in the monoculture and fourfold in the coculture after treatment with digested ZnO NP. This led to reactive oxygen species but showed no impact on cellular organelles, the metabolic activity, and the mitochondrial membrane potential. Only very small amounts of zinc (< 0.7%) reached the basolateral area, which is due to the unmodified transepithelial electrical resistance, permeability, and cytoskeletal morphology. Conclusions: Our results reveal that digested and, therefore, modified ZnO NP interact with cells of an intact intestinal barrier. But this is not associated with serious cell damage. Quelle: Artikel